Beta Bionics

Beta Bionics is a commercial stage medical technology company engaged in the design, development, and commercialization of innovative solutions to improve the health and quality of life of insulin-requiring people with diabetes (PWDs) by utilizing advanced adaptive algorithms to simplify and improve the treatment of their disease.

Overview Structured Data Issues Contributors

betabionics.com

Is a

Company attributes

Industry

Diabetes management

Diabetes mellitus

0

Pharmaceutical industry

Health technology

Location

Irvine, California

B2X

0

0

CEO

Founder

Pitchbook URL

pitchbook.com/profiles...163980-82

Number of Employees (Ranges)

51 – 2000

Email Address

jobs@betabionics.com

ir@betabionics.com

Investors

Wellington Management

Eventide Asset Management LLC

Yasar Corporation

0

RTW Investments LLC

Founded Date

2015

0

Total Funding Amount (USD)

60,000,000

Latest Funding Round Date

November 13, 2024

CFO

Latest Funding Type

Patents Assigned (Count)

1

Other attributes

Company Operating Status

Active

Latest Funding Round Amount (USD)

60,000,000

No article content yet.

Timeline

No Timeline data yet.

Funding Rounds

Products

Acquisitions

SBIR/STTR Awards

Patents

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more companies like Beta Bionics

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.

Open Query Tool

Golden Query Tool

By using this site, you agree to our Terms of Service.